Lactobacillus reuteri

Lactobacillus reuteri RC-14

RC-14 (ATCC 55845)

Supporting vaginal microbiome balance against BV and yeast.

Moderate Evidence130+ indexed studies

Quick Overview

At a Glance

Researched Benefits

  • Clinically studied to help reduce the recurrence of bacterial vaginosis — one of the most stubborn intimate health concerns women face
  • Naturally colonizes the vaginal tract from an oral dose, making it far more convenient than topical treatments or suppositories
  • Helps maintain a protective, low-pH vaginal environment that discourages yeast overgrowth and urinary tract infections
  • Excellent long-term safety profile with decades of research in women's health — well-tolerated even with regular daily use

Usage & Application

Clinically Studied Dosage

1–2 Billion CFU/day (oral), often combined with L. rhamnosus GR-1

Available Forms

Oral capsulesOral tabletsPowder sachetsProbiotic yogurt (functional food delivery)

Clinical Evidence

Rebuilding Vaginal Microbiome Balance After a Yeast Infection: Lactobacillus reuteri RC-14

Your vaginal microbiome is its own ecosystem — a finely tuned community of bacteria that, when balanced, keeps harmful invaders like BV-causing bacteria and Candida yeast in check. Lactobacillus reuteri RC-14 is a naturally occurring strain of friendly bacteria that was originally isolated from a healthy human urogenital tract, which is exactly why it's so effective at working in that environment. Unlike generic probiotics that mostly colonize the gut, RC-14 has a special ability: it can survive the journey through the digestive system and actually travel to and colonize the vaginal tract. Think of it like a skilled peacekeeper that knows the neighborhood — it settles in, produces lactic acid and hydrogen peroxide, lowers the local pH, and creates conditions where harmful microbes simply can't thrive. It's almost always studied alongside its partner strain, Lactobacillus rhamnosus GR-1, and together they form one of the most evidence-backed combinations in women's probiotic research.

For women who deal with the exhausting cycle of recurring bacterial vaginosis (BV), yeast infections, or urinary tract infections (UTIs), this strain has been a genuine game-changer in clinical settings. BV is notoriously stubborn — antibiotics clear it temporarily, but it often comes roaring back within weeks. Clinical research has shown that taking RC-14 alongside the standard antibiotic treatment dramatically reduces relapse rates, giving women longer windows of relief and better long-term outcomes. The mechanism is elegant: the probiotic repopulates the vaginal microbiome with beneficial Lactobacillus species, making it far harder for the problematic bacteria to reclaim their foothold. Women in clinical trials have reported fewer discharge episodes, less odor, reduced irritation, and a genuine improvement in day-to-day comfort. Beyond BV, RC-14 also shows meaningful benefits against vulvovaginal candidiasis (yeast infections) — it competes directly with Candida for space and secretes substances that inhibit yeast overgrowth. For women prone to UTIs, the colonization of the vaginal and urethral area with RC-14 helps block pathogenic bacteria like E. coli from ascending into the bladder, reducing the frequency of infections over time. Emerging research also suggests intriguing connections to mood and hormonal health, particularly in women experiencing menopause — where RC-14 may interact with estrogen receptor pathways to support emotional balance — though this exciting area still requires more clinical validation.

One of the standout qualities of Lactobacillus reuteri RC-14 is its excellent safety record, especially in women. It has been used in clinical studies without significant adverse effects, even with long-term oral supplementation. Since it is a naturally occurring human strain, the body tolerates it exceptionally well — there are no reports of systemic infections or serious side effects in healthy individuals. It is most commonly taken as an oral capsule (not a vaginal insert), which makes it far more convenient than topical treatments. The standard approach is to take it daily alongside a complementary probiotic strain for continuous microbiome support, particularly after completing a course of antibiotics when the vaginal flora is most vulnerable. Women who are pregnant, immunocompromised, or managing a serious vaginal infection should always consult their healthcare provider before starting any probiotic regimen. Beyond its core women's health applications, RC-14 is also bile-resistant and acid-tolerant, meaning it survives the digestive journey intact. This robustness makes it suitable for delivery in various formats, including yogurt and fermented foods, not just capsules. Whether you're trying to break a cycle of recurring BV or simply maintain a healthy vaginal microbiome as a preventive measure, RC-14 represents one of the most targeted and well-supported tools available in the probiotic world.


Common Questions

Frequently Asked Questions


Sources

Scientific References

Curated By

Clara Hayes

Clara Hayes

Lead Research Editor

Clara leads the curation and verification of microbiome research for our platform. With extensive experience in translating complex scientific literature into accessible insights, she ensures every strain profile is grounded in peer-reviewed evidence and contextual accuracy.

!

Medical Disclaimer

The information provided on probioticstrains.com is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Strain profiles and clinical summaries are compiled from published peer-reviewed literature. While we may evaluate or highlight specific commercial formulations, our insights are always grounded in available scientific evidence. Always consult a qualified healthcare provider before starting, changing, or stopping any supplement or health regimen.